Altrova Health Inc.

As of March 31, 2026, Altrova Health Inc. has 201.08M shares outstanding.

As of March 31, 2026, Altrova Health Inc. maintains a current ratio of 0.39, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended March 31, 2026, Altrova Health Inc. posted a negative return on equity (ROE) of -130.37, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -98.76, reflecting losses generated across the asset base.

Over the twelve months ended March 31, 2026, Altrova Health Inc. generated 141,536.00 in revenue and converted that into -4.69M in net income, yielding earnings per share of -0.03. EBITDA reached -1.98M, while operating income came in at -2.02M.

These figures are as of March 31, 2026. Total book value stands at 2.36M, with working capital of -885,448.00 providing operational flexibility.

Altrova Health Inc. produced -771,539.00 in operating cash flow over the twelve months ended March 31, 2026. After subtracting -357,528.00 in capital expenditures, free cash flow totaled -1.13M - equivalent to -0.01 per share.

These figures cover the twelve months ended March 31, 2026. The operating margin of -1,424.34 and net profit margin of -3,311.71 provide insight into operational efficiency.

Altrova Health Inc.'s most recent stock split took place on October 3, 2023 with a 4:1 split ratio.